Important Information for Submitting an Abstract
We invite healthcare professionals involved in original research or quality improvement projects related to cardiovascular risk reduction and disease management to submit an abstract. Only original abstracts that have not been previously published or presented prior to submitting to PCNA will be considered.
Submission of an abstract constitutes a commitment by the author to present a poster if accepted and a commitment by each author to sign a copyright transfer to the Journal of Cardiovascular Nursing.
Awards & Publication:
1. Two outstanding written abstracts (one in each category) will be selected for oral presentations. Winners will receive a $250 award and deliver a 10-minute oral presentation to participants during the program in the main arena.
2. During the Symposium, a first, second, or third place ribbon will be placed on winning posters. A $250 award will be given to the first place winners in each category.
3. Both oral presenters and all first, second and third place winners will be recognized during General Sessions on Sunday, April 7, and published in the Journal of Cardiovascular Nursing
4. Everyone who has a poster and is not an industry representative is eligible to be selected to present at the Moderated Poster Session on Saturday afternoon, April 6. This small group session will be moderated by a PCNA board or committee member. Each presenter would be allotted 10 minutes to present their work. Questions can be answered during the Poster Session in the Exhibit Hall.
The PCNA Abstract Review Committee will make selections using a blind review process. In order to be accepted for review, abstracts must adhere to the guidelines set forth in this Call for Abstracts and must be received via the PCNA online submission form no later than December 1, 2016. Authors will be notified by January 16, 2017 of acceptance.
General Submission Guidelines:
- Only original abstracts will be considered (not previously published or presented prior to submitting to PCNA)
- The abstract itself may not exceed a word count of 300, including tables. The 300-word limit does not include title or author(s) information.
- 11 point Calibri font is required
- Title must be left-aligned and ALL CAPITALIZED
- In the full abstract, please list full name followed by degrees/credentials, employer, and city/state for each author
- Be sure that street address, zip code, and grant support are NOT listed in abstracts.
- Any author may not be first author on more than two submissions.
- Any investigator may not present more than two posters.
- Industry representatives (i.e. from device/pharmaceutical/food companies) cannot be first author on any submitted abstracts to avoid a potential conflict of interest.
- Industry-related presenters may have a poster in the General Poster Sessions, but are not eligible for being published in the JCN or providing an oral presentation in order to avoid potential conflict of interest.
- When using abbreviations, spell out in full the first mention, followed by the abbreviation in parentheses.
- Check accuracy of spelling, grammar, and punctuation: Your poster abstract will appear in print exactly as you submit it; thus any errors, misspellings, incorrect hyphenations, or deviations from good grammatical usage will appear in the published abstract.
- Deadline for submission is 11:59 pm on December 1, 2016. Submissions received after this date will not be accepted for review.
- If you do not receive an e-mail confirmation within 24 hours after submitting your abstract online, it is your responsibility to contact the PCNA National Office to make sure we have received your submission.